Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE

Subcutaneous plasma‐derived human C1‐Inhibitor concentrate (pdC1INH) may be safe and effective for long‐term prophylaxis during pregnancy and lactation in hereditary angioedema patients.

Detalles Bibliográficos
Autores principales: Andarawewa, Shimalee, Aygören‐Pürsün, Emel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981658/
https://www.ncbi.nlm.nih.gov/pubmed/33768824
http://dx.doi.org/10.1002/ccr3.3743
_version_ 1783667557892358144
author Andarawewa, Shimalee
Aygören‐Pürsün, Emel
author_facet Andarawewa, Shimalee
Aygören‐Pürsün, Emel
author_sort Andarawewa, Shimalee
collection PubMed
description Subcutaneous plasma‐derived human C1‐Inhibitor concentrate (pdC1INH) may be safe and effective for long‐term prophylaxis during pregnancy and lactation in hereditary angioedema patients.
format Online
Article
Text
id pubmed-7981658
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79816582021-03-24 Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE Andarawewa, Shimalee Aygören‐Pürsün, Emel Clin Case Rep Case Reports Subcutaneous plasma‐derived human C1‐Inhibitor concentrate (pdC1INH) may be safe and effective for long‐term prophylaxis during pregnancy and lactation in hereditary angioedema patients. John Wiley and Sons Inc. 2021-02-06 /pmc/articles/PMC7981658/ /pubmed/33768824 http://dx.doi.org/10.1002/ccr3.3743 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Andarawewa, Shimalee
Aygören‐Pürsün, Emel
Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE
title Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE
title_full Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE
title_fullStr Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE
title_full_unstemmed Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE
title_short Subcutaneous C1‐Inhibitor Concentrate for prophylaxis during pregnancy and lactation in a patient with C1‐INH‐HAE
title_sort subcutaneous c1‐inhibitor concentrate for prophylaxis during pregnancy and lactation in a patient with c1‐inh‐hae
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981658/
https://www.ncbi.nlm.nih.gov/pubmed/33768824
http://dx.doi.org/10.1002/ccr3.3743
work_keys_str_mv AT andarawewashimalee subcutaneousc1inhibitorconcentrateforprophylaxisduringpregnancyandlactationinapatientwithc1inhhae
AT aygorenpursunemel subcutaneousc1inhibitorconcentrateforprophylaxisduringpregnancyandlactationinapatientwithc1inhhae

Ejemplares similares